May 17, 2021 — In patients receiving therapeutic hypothermia after suffering out-of-hospital cardiac arrest, those who ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
May 17, 2021 — The anticoagulant rivaroxaban (Xarelto), in addition to low-dose aspirin, significantly reduced the ...
May 17, 2021 — In patients who received a coronary stent for an ST-elevation myocardial infarction (STEMI) heart attack ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
![The Record Paradise RDN catheter uses a balloon catheter filled with water to cool the vessel wall as ultrasound-based ablation energy is delivered. It delivers a ring of ablative energy to a depth of 1-6 mm. Kirtane said it requires 2-3 sonications lasting 7 seconds each in each of the main renal arteries. #ACC21 #ACC2021 #RDN](/sites/default/files/styles/content_feed_large/public/field/image/Renal_Denervation_Recor_RDN_ablation_balloon.jpg?itok=OLduFSKx)
May 16, 2021 — Two months after undergoing renal denervation (RDN) with the ReCor Paradise renal denervation system ...
![The Boston Scientific Watchman device have performed better than expected in real-world patients outside of trials since it was introduced in 2015, according to data from the NCDR LAAO Registry. #ACC21 #ACC2021 #LAA #Watchman](/sites/default/files/styles/content_feed_large/public/field/image/Boston_Scientific___Watchman_2_FLX2_0.jpg?itok=gcOs3nnc)
May 15, 2021 - Transcatheter left atrial appendage occlusion (LAAO) with a Boston Scientific Watchman device was ...
May 15, 2021 — Patients with an elevated risk of stroke due to heart rhythm problems, or atrial fibrillation (AFib) ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
May 15, 2021 — The ADAPTABLE trial found no significant differences in cardiovascular events or major bleeding in ...
May 15, 2021 — The anticoagulant apixaban (Eliquis) was not superior to standard of care following transcatheter aortic ...
![There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone. #SCAI21 #SCAI2021 Creating a card0-renal program.](/sites/default/files/styles/content_feed_large/public/field/image/Kidney_Heart_care_GettyImages-1130392754.jpg?itok=ntxNwYfa)
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
![Explaining the Emory TMVR angle. Discordance between mitral annular centerline (yellow lines) and valve orientation imposed by guidewire position within the LV apex (red dashed lines). (B) Valve intrinsic angle (α) is determined by external skirt height. (C) When annular-apical “Emory” angle (red curves) exceeds α (blue curve), annular skirt apposition is not possible, causing PVL (red arrows). (D) The valve is oriented perpendicular to the annual plane using an exteriorized apical guidewire.](/sites/default/files/styles/content_feed_large/public/field/image/Emory_angle_with_externalized_wire_Emory_main_slide.jpg?itok=7F_hw6V4)
The mitral valve anatomy is extremely complex, which has caused many challenges for transcatheter mitral valve ...
Tom Jones, M.D., director, cardiac catheterization laboratories, Seattle Children’s Hospital, and principle investigator ...
May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
May 12, 2021 — Preliminary results of a clinical trial, presented today at the AATS 101st Annual Meeting, showed that a ...
May 12, 2021 — HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced that the National ...
![The BioCardia cardiac stem cell CardiAMP trial is a Phase III study looking at the efficacy of using stem cells to improve heart function in heart failure patients. It is the first trial for this technology to reach Phase III trial.](/sites/default/files/styles/content_feed_large/public/field/image/BioCardia_BioAMP_Stem_cell_trial.jpg?itok=cghJuqdl)
Heart failure remains an unheralded global pandemic, costing society billions of dollars each year.[1,2] Projections ...